March 19, 2024
CMS released its annual monitoring report on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
Only 203 suppliers have participated in the benefit out of nearly 1,500 eligible infusion pharmacies and thousands of home health agencies. Most providers have made only a handful of visits with just 7 accounting for more than half (55%) of all HIT visits. This lack of participation leaves many states with no participating providers for Part B HIT services.
Without a per infusion day payment for pharmacy services, access will continue to wane. Medicare beneficiaries deserve the same site of care options as commercial insurance patients – which is why NHIA is advocating for the passage of the Preserving Patient Access to Home Infusion Act.
Help us support this critical legislation by sending a message to your Congressional representatives.
NHIA commends CMS for listening to stakeholders and deciding not to move forward at this time with the proposed changes to HCPCS codes and billing units for immune globulin products.
The National Home Infusion Foundation’s Wellness Challenge is returning this September, and we’re excited to invite your organization to sponsor a team and make a meaningful impact on our industry!
This proposal to modify the criteria for the use of an infusion pump should not be viewed as a solution to the broader access challenges facing Medicare beneficiaries who could safely receive infusion therapy at home.
